SPYRAL HTN OFF-MED Study

28 August 2017 (11:00 - 11:10)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Professor Michael Boehm

Saarland University Hospital, Homburg (Germany)

17 More presentations in this session

Presentation thumbnail

Discussant review: SPYRAL HTN OFF-MED Study

Professor B. Williams (London, GB)

Presentation thumbnail

Panel discussion.

Presentation thumbnail

Apixaban vs conventional therapy in anticoagulation-naive patients with atrial fibrillation undergoing cardioversion: The EMANATE Trial

Professor M. Ezekowitz (Philadelphia, US)

Presentation thumbnail

Discussant review:Apixaban vs conventional therapy in anticoagulation-naive patients with atrial fibrillation undergoing cardioversion: The EMANATE Trial

Professor J. Nielsen (Aarhus, DK)

Presentation thumbnail

Panel discussion.

Access the full session

Session thumbnail

Hot Line: Late-Breaking Clinical Trials 2

The Event

ESC Congress 2017

28 August 2017 11:00 CET

You may be interested in

Congress Presentation

Nighttime blood pressure reductions after radiofrequency renal denervation through 24 months in patients with uncontrolled hypertension: pooled analysis from the SPYRAL HTN trials

30 August 2024

Congress Presentation

Heart failure events in a clinical trial of arterial hypertension. The acquittal of the SPRINT trial.

31 August 2020

Congress Presentation

Randomized controlled pilot study comparing different digital solutions for the management of hypertensive patients: the HSMonitor-IT study.

5 April 2025

Congress Presentation

Add-on treatment with zilebesiran for inadequately controlled hypertension: KARDIA-2 RCT

1 September 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources